SLS R&D to Revenue
Sellas Life Sciences Group Inc · R&D to Revenue
SLS R&D to Revenue
Latest reported0.00%period ending
SLS Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
SLS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 461.1% | |
| 0% | |
| 0% | |
| 181.8947% | |
| 75.1579% | |
| 145.8421% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -76.1742% | |
| 0% | |
| 212.8031% | |
| 211.8182% | |
| 196.3067% | |
| 433.642% | |
| 346.1604% | |
| 311.5509% | |
| 538.041% | |
| 310.5128% | |
| 0% | |
| 0% | |
| 197.6156% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 718.93% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |